PMC6968524_01
UHAg and itraconazole levels over time.
ZJCH_A_1698263_F0001_B.jpg
PMC6968524_01_ZJCH_A_1698263_F0001_B.jpg
F0001
Histoplasma Quantitative Enzyme Immunoassay). Her itraconazole levels were monitored every 3-4 months and were in therapeutic range throughout her treatment, and she clinically improved [Figure 1]. She increased water intake and provided a repeat sample seven days later that showed a 'Negative' UHAg result [Figure 1].